SPRR2A and metastatic malignant neoplasm in the lymph nodes: Then, we assessed the associations between SPRR2A expression and various clinicopathological parameters, including gender, age, tumor size, histological differentiation, Lauren classification, lymph node metastasis, and clinical stage.